Table 4. List of studies included in the network meta-analysis.
Region | First Author | Year | Index Test(s) | Ref. |
---|---|---|---|---|
East Asia and Pacific | Castonguay -Vanier J | 2013 | Antigen (RDT) | [20] |
East-Asia and Pacific | Handojo I | 2000 | Antibody (ELISA, IgG) | [21] |
Antibody (ELISA, IgM) | ||||
East-Asia and Pacific | Limpitikul W | 2014 | Antibody (ELISA, IgG) | [22] |
Antibody (ELISA, IgM) | ||||
East-Asia and Pacific | Moore CE | 2014 | Antibody (Lateral flow, IgM) | [23] |
PCR/DNA | ||||
East-Asia and Pacific | Nugraha J | 2012 | Antigen (TUBEX TP, O12) | [24] |
South Asia | Alam AS | 2011 | Widal slide (O or H) 1:160 (O or H) | [25] |
South Asia | Ambati SR | 2007 | nested PCR (blood) | [26] |
South Asia | Anusha R | 2007 | Antibody (Enteroheck WB, IgM) | [27] |
South Asia | Beig FK | 2010 | Antibody (Typhidot, IgM) | [28] |
Diazo | ||||
Widal (H) 1:200 (H) | ||||
South Asia | Das S | 2013 | Antibody (Lateral flow, IgM or IgG) | [29] |
Widal (O) 1:180 (O) | ||||
South Asia | Dutta S | 2006 | Antibody (TUBEX, IgM) | [30] |
Antibody (Typhidot, IgM) | ||||
Widal (O) | ||||
South Asia | Islam K | 2016 | Antibody (TPT test, S.Typhi specific IgA) | [31] |
Antibody (TUBEX, IgM) | ||||
Antibody (Typhidot, IgM or IgG) | ||||
South Asia | Kalhan R | 1998 | Antigen (Reverse Passive Hemagluttination) | [12] |
South Asia | Khan IH | 2016 | Antibody (Lateral flow, IgG) | [32] |
South Asia | Khanam F | 2013 | Antibody (TPT test, S.Typhi specific IgA) | [33] |
South Asia | Kulkarni ML | 1994 | Widal (H) 1:160 (H) | [34] |
Widal (O) 1:160 (O) | ||||
South Asia | Kumar KS | 2016 | Antibody (Typhidot, IgG) | [35] |
Antibody (Typhidot, IgM) | ||||
South Asia | Narayanappa D | 2010 | Antibody (Typhidot, IgM) | [36] |
South Asia | Nizami SQ | 2006 | Antibody (TUBEX, IgM) | [37] |
Antibody (Typhidot, IgM) | ||||
nested PCR (blood) | ||||
South Asia | Prakash P | 2005 | nested PCR (blood) | [38] |
South Asia | Prakash P | 2007 | Antibody (Typhidot, IgG) Widal slide (O or H) 1:160 (O or H) |
[39] |
Antibody (Typhidot, IgM) | ||||
PCR/DNA | ||||
South Asia | Rahman M | 2007 | Antibody (ELISA, IgG or IgM) | [40] |
Antibody (ELISA, IgG) | ||||
Antibody (ELISA, IgM) | ||||
Antibody (TUBEX, IgM) | ||||
Widal slide (O or H) 1:160 (O or H) | ||||
South Asia | Saha SK | 1996 | Widal slide (H) 1:160 (H) | [41] |
Widal slide (O) 1:80 (O) | ||||
South Asia | Shehabi AA | 1981 | Widal (O or H) 1:80 (O or H) | [42] |
South Asia | Sheikh A | 2009 | Antibody (ELISA, IgA) | [43] |
South Asia | Srivastava L | 1986 | Antibody (ELISA, IgG) | [44] |
Antibody (ELISA, IgM) | ||||
Widal (O) 1:80 (O) | ||||
South Asia | Tennant SM | 2015 | PCR/DNA | [45] |
South Asia | Zaka-ur-Rab Z | 2012 | Antibody (ELISA, IgA) | [46] |
Sub-Saharan Africa | Al-Emran HM | 2016 | PCR/DNA | [47] |
Sub-Saharan Africa | Cheesbrough JS | 1997 | Antibody (ELISA, total Ig) | [48] |
Sub-Saharan Africa | Ley B | 2010 | Widal (H) 1:80 (H) | [49] |
Widal (O) 1:80 (O) | ||||
Sub-Saharan Africa | Ley B | 2011 | Antibody (TUBEX, IgM) | [50] |